Liver Cancer News and Research

RSS

Liver cancer is more common in older people. Over half of people newly diagnosed with liver cancer are age 65 and over. Liver cancer is more common in men than in women. Liver cancer rates are highest among Asians and Pacific Islanders, most likely because of higher prevalence of viral Hepatitis infection. Liver cancer rates are lower among whites than Blacks or Asians and Pacific Islanders. At this time, we do not know exactly what causes cancer of the liver. There are several different types of liver cancer. The most common type is associated with long-term excessive alcoholic beverage use, scarring of the liver (cirrhosis), and Hepatitis B virus or Hepatitis C virus infection. Long-term use of anabolic steroids can also increase the risk of getting liver cancer. Smoking is also believed to increase the risk of getting liver cancer.

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Experts from United European Gastroenterology (UEG), presenting at the European Digestive Cancer Days Conference in Prague today, are calling on European governments to focus their efforts on developing early diagnosis techniques, in order to save thousands of lives from digestive cancers including a more targeted approach to ensure at risk patients don’t ‘slip through the early-detection net’.

28 Sep 2017

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Cancer vaccines may need to better target T cells that can hold up to the long fight against cancer, scientists report.

27 Sep 2017

Research could lead to improvements in treating diseases caused by mutations in genes

Research carried out by academics at Northumbria University, Newcastle could lead to improvements in treating patients with diseases caused by mutations in genes, such as cancer, cystic fibrosis and potentially up to 6,000 other inherited conditions.

19 Sep 2017

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Hepatoblastoma is a rare pediatric liver cancer, usually diagnosed in the first three years of life. Histological methods are used to distinguish between the different subtypes of hepatoblastoma.

18 Sep 2017

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

Artemisinin, a potent anti-malarial drug, has been widely hailed as a promising alternative cancer treatment. Scientists from the National University of Singapore recently showed that its anti-cancer properties could be enhanced by 10 folds when used in combination with Aminolaevulinic acid, a photosensitizer or a drug which, upon exposure to light, leads to generation of free radicals that can kill cells.

18 Sep 2017

EHR-based prompt in primary care increases HCV screening rates among baby boomers

In a recent study, screening rates for hepatitis C virus (HCV) infection among baby boomers increased fivefold in the year following implementation of an electronic health record (EHR)-based prompt for primary care physicians.

14 Sep 2017

Researchers discover major mechanism in development of liver cancer

Liver cancer is the second-leading cause of cancer-related death and represents the fastest rising cancer worldwide. In most cases, the tumor develops in patients with chronic liver disease.

11 Sep 2017

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Patients with the most common type of liver cancer who are taking the chemotherapy drug sorafenib can begin their treatment with a lower dose than is currently considered standard, and it will not affect how long they live when compared to patients who start on the full dose.

6 Sep 2017

Study findings could one day help doctors better predict survival of liver cancer patients

A new study of a molecule that regulates liver-cell metabolism and suppresses liver-cancer development shows that the molecule interacts with thousands of genes in liver cells, and that when levels of the molecule go down, which often happens during liver-cancer development, the activity of certain cancer-promoting genes goes up.

23 Aug 2017

Altered secretion behavior of fatty liver can lead to damage of other organs

Nonalcoholic fatty liver disease is becoming more and more common. Approximately every third adult in the industrialized countries has a morbidly fatty liver.

18 Aug 2017

Researchers identify gene that could play role in energy requirements of liver cancer cells

A little-studied gene may explain how some liver cancer cells obtain the nutrition they need to proliferate, according to new research from the University of Maryland.

10 Aug 2017

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Investigators at Children's Hospital Los Angeles have succeeded in better defining a rare pediatric malignant liver disease -- a necessary step in achieving an optimum treatment.

9 Aug 2017

Experimental drug protects mice from obesity-related liver disease

A drug developed at the University of Rochester Medical Center protected mice from one of the many ills of our cheeseburger and milkshake-laden Western diet -- non-alcoholic fatty liver disease.

3 Aug 2017

FDA approves new treatment for all HCV genotypes 1-6

The U.S. Food and Drug Administration today approved Mavyret (glecaprevir and pibrentasvir) to treat adults with chronic hepatitis C virus (HCV) genotypes 1-6 without cirrhosis (liver disease) or with mild cirrhosis, including patients with moderate to severe kidney disease and those who are on dialysis.

3 Aug 2017

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

Yesterday the U.S. Food and Drug Administration gave its approval to Mavyret (glecaprevir and pibrentasvir) for the treatment of adults with chronic hepatitis C infection. These patients are infected with the Hepatitis C virus (HCV) of genotypes 1-6 and are those that have not developed liver cirrhosis or those who have developed mild cirrhosis. The approval for Mavyret was given to AbbVie Inc.

3 Aug 2017

Liver Cancer News and Research

Further Reading

Experts call for greater focus on effective screening methods to help save lives from digestive cancers

Cancer vaccines need to target immune fighters that can withstand battle against malicious tumors

Research could lead to improvements in treating diseases caused by mutations in genes

EPFL scientists discover metabolic differences between hepatoblastoma subtypes

Combination of anti-malarial drug and photosensitizer could effectively kill cancer cells

EHR-based prompt in primary care increases HCV screening rates among baby boomers

Researchers discover major mechanism in development of liver cancer

Reduced dose of chemotherapy has no effect on overall survival of liver cancer patients

Study findings could one day help doctors better predict survival of liver cancer patients

Altered secretion behavior of fatty liver can lead to damage of other organs

Researchers identify gene that could play role in energy requirements of liver cancer cells

CHLA researchers succeed in better defining rare pediatric malignant liver disease

Experimental drug protects mice from obesity-related liver disease

FDA approves new treatment for all HCV genotypes 1-6

FDA approves new combo drug Mavyret for adults with Hepatitis C infection

AbbVie hosts roundtable meeting to agree priority actions needed to eliminate hepatitis C in London

Men with hepatitis B more likely to develop severe liver disease despite lifestyle choices

Princeton scientists test cell-culture system to aid study of HBV infections

Parents have substantial role in curbing drinking habits of adolescents

IBS scientists create first nanoparticle-based tissue adhesive to seal bleeding and guide surgery

Bringing real-time analytics to downstream bioprocess monitoring

Designing fluidic architecture for scalable diagnostic platforms

Evaluating new approaches for rare disease genomics

Latest News